Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 1183, pseudogene (RNU6-1183P)** is a human pseudogene related to U6 small nuclear RNA, a highly conserved non-coding RNA essential for the spliceosome complex and pre-mRNA splicing[1][2]. Unlike functional U6 snRNA genes, this pseudogene is considered non-functional, meaning it does not encode a functional RNA product involved in the splicing process[2]. Pseudogenes such as RNU6-1183P often arise from duplication or retrotransposition events and generally lack regulatory elements or functional sequences necessary for normal cellular roles. While some pseudogenes can act as regulatory elements (e.g., miRNA decoys) or influence gene expression, there is no published evidence that RNU6-1183P plays such a role. It is not considered a therapeutic target, biomarker, or pharmacologically relevant molecule[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1183, pseudogene (RNU6-1183P).